Synthetic anthocyanidins and their antioxidant properties

Anthocyanidins were synthesized to study the effect of methoxy substitution on the B ring to their antioxidant property. Comparative FRAP studies show 2′- and 4′-methoxy substituents have higher antioxidant activities, which may be attributed to both resonance and inductive effects.Graphical abstract:Anthocyanidins as reducing agents Electronic supplementary material The online version of this article (doi:10.1186/s40064-015-1250-x) contains supplementary material, which is available to authorized users

Chromosome X-encoded Cancer/Testis antigens are less frequently expressed in non-seminomatous germ cell tumors than in seminomas

Cancer/Testis (CT) antigens are normally only expressed in germ cells and yet are aberrantly activated in a wide variety of human cancers. Most chromosome X-encoded CT antigens (CT-X) show restricted expression in pre-meiotic germ cells in adult testis, except for the expression of SPANX in post-meiotic germ cells. In the present study, the expression of eight CT-X antigens (MAGE-A, NY-ESO-1, GAGE, MAGE-C1/CT7, MAGE-C2/CT10, CT45, SAGE1, and SPANX) in non-seminomatous germ cell tumors was evaluated immunohistochemically, including 24 embryonal carcinomas, 20 yolk sac tumors, 9 teratomas, and 3 choriocarcinomas, and the results were compared to our previous study of 77 classic seminomas and 2 spermatocytic seminomas. SPANX was not detected in any germ cell tumors tested. Spermatocytic seminoma showed strong expression of all CT-X antigens tested (except SPANX), reflecting their origin from adult CT-Xpositive pre-meiotic germ cells. Classic seminomas, originating from prenatal gonocytes, showed widely variable frequency of CT-X antigen expression, ranging from > 80% (CT7, CT10, CT45, and GAGE), 63% (MAGE-A), 18% (NY-ESO-1) to only 4% (SAGE1). In comparison, non-seminomatous germ cell tumors expressed CT-X antigens much less frequently and usually only in small subsets of tumor cells. Intratubular germ cell neoplasia (ITGCN) were mostly CT-X-negative, even in CT-X positive classic seminomas. These findings indicate that CT-X antigens are not expressed in the fetal precursor cells for germ cell tumors, and their expression likely reflects germ cell differentiation of the neoplastic cells (in seminomas) or aberrant gene activation as cancer antigens (in non-seminomatous tumors)

The Effect of Altruistic Tendency on Fairness in Third-Party Punishment

Third-party punishment, as an altruistic behavior, was found to relate to inequity aversion in previous research. Previous researchers have found that altruistic tendencies, as an individual difference, can affect resource division. Here, using the event-related potential (ERP) technique and a third-party punishment of dictator game paradigm, we explored third-party punishments in high and low altruists and recorded their EEG data. Behavioral results showed high altruists (vs. low altruists) were more likely to punish the dictators in unfair offers. ERP results revealed that patterns of medial frontal negativity (MFN) were modulated by unfairness. For high altruists, high unfair offers (90:10) elicited a larger MFN than medium unfair offers (70:30) and fair offers (50:50). By contrast, for low altruists, fair offers elicited larger MFN while high unfair offers caused the minimal MFN. It is suggested that the altruistic tendency effect influences fairness consideration in the early stage of evaluation. Moreover, the results provide further neuroscience evidence for inequity aversion

The Effect of Altruistic Tendency on Fairness in Third-Party Punishment

Third-party punishment, as an altruistic behavior, was found to relate to inequity aversion in previous research. Previous researchers have found that altruistic tendencies, as an individual difference, can affect resource division. Here, using the event-related potential (ERP) technique and a third-party punishment of dictator game paradigm, we explored third-party punishments in high and low altruists and recorded their EEG data. Behavioral results showed high altruists (vs. low altruists) were more likely to punish the dictators in unfair offers. ERP results revealed that patterns of medial frontal negativity (MFN) were modulated by unfairness. For high altruists, high unfair offers (90:10) elicited a larger MFN than medium unfair offers (70:30) and fair offers (50:50). By contrast, for low altruists, fair offers elicited larger MFN while high unfair offers caused the minimal MFN. It is suggested that the altruistic tendency effect influences fairness consideration in the early stage of evaluation. Moreover, the results provide further neuroscience evidence for inequity aversion

Analysis of Major Aroma Compounds in Fermented and Prepared Hawthorn Wine

In this study, liquid-liquid extraction-solvent assisted flavor evaporation (LLE-SAFE), headspace solid phase microextraction extraction (HS-SPME), gas chromatography-quadrupole-mass spectrometry (GC-Quadrupole-MS), gas chromatography-orbitrap-mass spectrometry (GC-Orbitrap-MS) and gas chromatography-olfactometry (GC-O) were used in combination to identify the volatile components in a fermented hawthorn wine (SBL-J) and a prepared hawthorn wine (FS), and the results of sensory analysis, modified frequency (MF) and odor activity value (OAV) were used to determine the key aroma compounds. Totally 89 aroma compounds were identified by LLE-SAFE/GC-O-MS. In addition, 29 and 38 aroma compounds with MF values of more than 20% were found in SBL-J and FS, respectively. A total of 123 volatile components were detected by HS-SPME/GC-Quadrupole-MS and HS-SPME/GC-Orbitrap-MS and there were 29 and 33 aroma compounds with OAV of greater than 1 (0.1 for esters) identified in SBL-J and FS, respectively. 2-Methybutyl acetate, ethyl hexanoate, ethyl octanoate and phenylethyl alcohol were the key aroma compounds in the two samples. To our knowledge, 2-methybutyl acetate, ethyl isovalerate, (E,E)-2,4-hexadienoic acid ethyl ester and ethyl butyrate, were identified for the first time as the key aroma components of hawthorn wine

Multiple Cancer/Testis Antigens Are Preferentially Expressed in Hormone-Receptor Negative and High-Grade Breast Cancers

BACKGROUND: Cancer/testis (CT) antigens are protein antigens normally expressed only in germ cells of testis, and yet are expressed in a proportion of a wide variety of human cancers. CT antigens can elicit spontaneous immune responses in cancer patients with CT-positive cancers, and CT antigen-based therapeutic cancer vaccine trials are ongoing for "CT-rich" tumors. Although some previous studies found breast cancer to be "CT-poor", our recent analysis identified increased CT mRNA transcripts in the ER-negative subset of breast cancer. METHODOLOGY/PRINCIPAL FINDINGS: In this study, we performed a comprehensive immunohistochemical study to investigate the protein expression of eight CT genes in 454 invasive ductal carcinomas, including 225 ER/PR/HER2-negative (triple-negative) carcinomas. We found significantly more frequent expression of all eight CT antigens in ER-negative cancers, and five of them--MAGEA, CT7, NY-ESO-1, CT10 and CT45, were expressed in 12-24% of ER-negative cancers, versus 2-6% of ER-positive cancers (p<0.001 to 0.003). In comparison, GAGE, SAGE1 and NXF2 were only expressed in 3-5% of ER-negative and 0-2% of ER-positive cancers. ER-negative cancers were also more likely to simultaneously co-express multiple CT antigens, with 27% (34/125) of ER-negative, CT-positive tumors expressing three or more CT antigens. HER2 status had no consistent effect on CT expression, and triple-negative carcinomas showed similar frequencies of MAGEA and NY-ESO-1 expression as ER-negative/HER2-positive carcinomas. More frequent CT expression was also found in tumors with higher nuclear grade (p<0.001 to p = 0.01) and larger in size (>2 cm). CONCLUSIONS/SIGNIFICANCE: CT antigens are preferentially expressed in hormone receptor-negative and high-grade breast cancer. Considering the limited treatment options for ER/PR/HER2 triple-negative breast cancer, the potential of CT-based immunotherapy should be explored

Comparative genomic analyses of Cutibacterium granulosum provide insights into genomic diversity

Cutibacterium granulosum, a commensal bacterium found on human skin, formerly known as Propionibacterium granulosum, rarely causes infections and is generally considered non-pathogenic. Recent research has revealed the transferability of the multidrug-resistant plasmid pTZC1 between C. granulosum and Cutibacterium acnes, the latter being an opportunistic pathogen in surgical site infections. However, there is a noticeable lack of research on the genome of C. granulosum, and the genetic landscape of this species remains largely uncharted. We investigated the genomic features and evolutionary structure of C. granulosum by analyzing a total of 30 Metagenome-Assembled Genomes (MAGs) and isolate genomes retrieved from public databases, as well as those generated in this study. A pan-genome of 6,077 genes was identified for C. granulosum. Remarkably, the ‘cloud genes’ constituted 62.38% of the pan-genome. Genes associated with mobilome: prophages, transposons [X], defense mechanisms [V] and replication, recombination and repair [L] were enriched in the cloud genome. Phylogenomic analysis revealed two distinct mono-clades, highlighting the genomic diversity of C. granulosum. The genomic diversity was further confirmed by the distribution of Average Nucleotide Identity (ANI) values. The functional profiles analysis of C. granulosum unveiled a wide range of potential Antibiotic Resistance Genes (ARGs) and virulence factors, suggesting its potential tolerance to various environmental challenges. Subtype I-E of the CRISPR-Cas system was the most abundant in these genomes, a feature also detected in C. acnes genomes. Given the widespread distribution of C. granulosum strains within skin microbiome, our findings make a substantial contribution to our broader understanding of the genetic diversity, which may open new avenues for investigating the mechanisms and treatment of conditions such as acne vulgaris

Impact of opioid-free analgesia on pain severity and patient satisfaction after discharge from surgery: multispecialty, prospective cohort study in 25 countries

Background: Balancing opioid stewardship and the need for adequate analgesia following discharge after surgery is challenging. This study aimed to compare the outcomes for patients discharged with opioid versus opioid-free analgesia after common surgical procedures.Methods: This international, multicentre, prospective cohort study collected data from patients undergoing common acute and elective general surgical, urological, gynaecological, and orthopaedic procedures. The primary outcomes were patient-reported time in severe pain measured on a numerical analogue scale from 0 to 100% and patient-reported satisfaction with pain relief during the first week following discharge. Data were collected by in-hospital chart review and patient telephone interview 1 week after discharge.Results: The study recruited 4273 patients from 144 centres in 25 countries; 1311 patients (30.7%) were prescribed opioid analgesia at discharge. Patients reported being in severe pain for 10 (i.q.r. 1-30)% of the first week after discharge and rated satisfaction with analgesia as 90 (i.q.r. 80-100) of 100. After adjustment for confounders, opioid analgesia on discharge was independently associated with increased pain severity (risk ratio 1.52, 95% c.i. 1.31 to 1.76; P &lt; 0.001) and re-presentation to healthcare providers owing to side-effects of medication (OR 2.38, 95% c.i. 1.36 to 4.17; P = 0.004), but not with satisfaction with analgesia (beta coefficient 0.92, 95% c.i. -1.52 to 3.36; P = 0.468) compared with opioid-free analgesia. Although opioid prescribing varied greatly between high-income and low- and middle-income countries, patient-reported outcomes did not.Conclusion: Opioid analgesia prescription on surgical discharge is associated with a higher risk of re-presentation owing to side-effects of medication and increased patient-reported pain, but not with changes in patient-reported satisfaction. Opioid-free discharge analgesia should be adopted routinely

Ethylene carbonate ethoxylation on aromatic nitrogen nucleophiles

Although ethoxylation reactions are commonly used, currently used reagents are hazardous, toxic, and/or explosive. Ethylene carbonate has been put forth as an inexpensive, nontoxic, and “green” potential ethoxylation reagent. Herein we study a base-catalyzed ethyl alcohol transfer from ethylene carbonate to indole. The 19F NMR method was used to quantify the product formation yields. Ethylene carbonate is an effective ethoxylation reagent for indoles. An excess use of ethylene carbonate is needed for the reaction to complete in a reasonable amount of time. There are no significant differences between the use of catalytic amount of different bases/nucleophiles, thus catalytic amounts of Cs 2CO3 and DABCO are further explored. As time increases, more side product forms. When DABCO is used as the catalyst, DMSO is recommended as the solvent for the reaction. When Cs 2CO3 is used as the catalyst, DMF is recommended as the solvent for the reaction. To date, our best reaction condition allows us to collect 67% of desired product. More experiments are needed to explore the optimal reaction condition so that an effective base-catalyzed ethylene carbonate ethoxylation on indole nucleophile can be developed, and eventually a general base-catalyzed ethylene carbonate ethoxylation reaction can be applied on various aromatic nitrogen nucleophile substrates